# How Women Can Protect Their Hearts with Dr. Jeremy London

**Channel:** Dr. Mary Claire Haver, MD
**Source:** https://www.youtube.com/watch?v=iWJ5mmmG8z0
**Transcript page:** https://www.withtranscript.ai/video/iWJ5mmmG8z0

## Chapters

- 0:04 — New 2026 Cardiovascular Guidelines Overview
- 5:11 — Women's Risk Factors and Testing Explained
- 18:43 — Cholesterol Medications and GLP-1s
- 33:22 — Exercise and Nutrition for Heart Health
- 42:32 — Sleep as a Cardiovascular Risk Factor
- 47:20 — Action Plan and Final Takeaways

## Transcript

**[0:04] Speaker A:** The views and opinions expressed on Unpause are those of the talent and guests alone and are provided for informational and entertainment purposes only. No part of this podcast or any related materials are intended to be a substitute for professional medical advice, diagnosis, or treatment. Welcome back. There was so much ground to cover with Dr. Jeremy London that we decided to split the episode into two parts. If you missed part one, I hope you'll go back and listen. But for now, here's the rest of our conversation. This podcast is sponsored by Midi Health, the first virtual clinic created for women, by women, for the treatment of menopause. Don't let anyone tell you menopause is something you have to suffer through alone. Midi can help. Visit joinmidi.com to learn more. The American College of Cardiology, American Heart Association just released the most significant update to cardiovascular risk guidelines in eight years.

**[1:01] Speaker A:** Um were you excited about this?

**[1:03] Speaker B:** Um excited. I was glad. I was I think it's a great first step.

**[1:09] Speaker A:** Okay.

**[1:10] Speaker B:** I I think excitement would be maybe overstatement. But you know, you got to start somewhere and and look, it's like turning a battleship with a lot of the bigger institutions. You can't expect change

**[1:23] Speaker A:** I completely understand.

**[1:25] Speaker B:** Right. In a you know, when something has been ingrained for a longer period of time, but you have to start somewhere. And I think this is a great

**[1:32] Speaker A:** First step.

**[1:33] Speaker B:** Absolutely. Great first step. Very encouraging first step.

**[1:36] Speaker A:** So the 2026 guideline on the management of dyslipidemia basically cat cholesterol that's not where we want it to be, replaces the 2018 guidelines and the key additions include um a prevent risk calculator.

**[1:52] Speaker B:** Mhm.

**[1:52] Speaker A:** What is that?

**[1:54] Speaker B:** Yeah, so that is primarily a cardiology tool.

**[1:57] Speaker A:** Mhm.

**[1:57] Speaker B:** And it basically takes all your health demographic data and then spits out a number.

**[2:04] Speaker A:** Okay. We have one for osteoporosis we use. We have the Gail model and Tyler Kuzik we use for breast cancer. So I'm assuming this is a similar kind of.

**[2:12] Speaker B:** And I don't know how you feel personally. I

**[2:15] Speaker A:** They're all They're not perfect.

**[2:17] Speaker B:** Exactly. And I think that it's it's always a nice contour to decision making, but I find it I can find it very misleading and sometimes misguided.

**[2:34] Speaker A:** Okay.

**[2:35] Speaker B:** Pulmonologist that I worked with years ago said to me He said, you know, knowing the protocols is the practice of medicine. Knowing when and when not to apply them is the art of medicine.

**[2:47] Speaker A:** Okay.

**[2:47] Speaker B:** And I think that tools like the calculator are wonderful as a starting point. But at some point somebody's got to sit down and examine the patient, listen to the patient, and make a decision utilizing that information, not as the stop.

**[3:05] Speaker A:** One of the big changes that looked to me was this universal LPA LP little A screening. Do you want to talk about that?

**[3:13] Speaker B:** Yeah. And I think that the history with this is interesting. It's not something new, but because it was genetic, the thought was, well, we can't do anything about it. So we might as well not test for it, which I think is not the best mindset, particularly when we're looking at something as multifactorial as as cardiovascular disease. But it isn't wrong. Like, you know, if you're not going to do something different with the test results, maybe you shouldn't test for it. I don't think that's an unreasonable mindset when you're thinking about risk benefits for patients. But in this case I I do think it was a mistake because it's important to know whether or not you have LPA or not because it puts you at such an a dramatic increased risk. Again, going back to this ability to attack the vessel wall, cause it local inflammation, and be thrombotic.

**[4:05] Speaker B:** It's like the perfect storm. And no, you might not be able to run from your genes clearly, but that's not the goal.

**[4:14] Speaker A:** You can intervene.

**[4:15] Speaker B:** Right. The goal is to be intellectually honest about where you stand, what your risk is, and now how do I modify all these things that I can modify? Don't you want to know about that risk as early as possible so that you can be more aggressive? That's the advantage.

**[4:32] Speaker A:** And then they also have an apoB measurement.

**[4:34] Speaker B:** Which is critical because that again

**[4:36] Speaker A:** didn't exist before.

**[4:38] Speaker B:** not. Well, people were checking apoBs. They're not on the standard panel in most in most labs. They will be as a result of these guidelines. That's the hope. And And that's the whole idea that we were talking about earlier, that LDL is not the whole story. It's a starting place. This idea of it's about the trucks on the road. It's about how many dangerous particles do you have and for how long floating in your bloodstream.

**[5:01] Speaker A:** And then for the first time in a major Heart Association guideline, early menopause before age 45 was formally classified as a cardiovascular risk enhancer.

**[5:11] Speaker B:** Yeah.

**[5:12] Speaker A:** So something we've kind of known in my world, but like it's really nice to see the cardiologist waving a flag and saying not okay.

**[5:20] Speaker B:** That's why I said this is a huge first step. Now we'll see you know, this is one thing.

**[5:27] Speaker A:** Cuz it means menopause is now formally part of her cardiovascular conversation.

**[5:31] Speaker B:** Right.

**[5:32] Speaker A:** Yeah.

**[5:32] Speaker B:** I mean, you know, is this going to affect change in practice? That's, you know, particularly when you have people that have been doing it for 20 25 years.

**[5:40] Speaker A:** I feel like these conversations, sharing this information on social, patients are going in and asking.

**[5:45] Speaker B:** Which is

**[5:45] Speaker A:** And volunteering the information.

**[5:47] Speaker B:** Absolutely. Which is real You know, I'm sure you you feel the same way just meeting you and talking to you about the way that you practice medicine, it's a relationship.

**[5:58] Speaker A:** Mhm.

**[5:59] Speaker B:** You know, it 's not a matter of patients coming in and you telling them what to do. It's a It's a two-way street. Well, a a relationship requires communication and it requires both people making effort.

**[6:13] Speaker A:** Mhm.

**[6:14] Speaker B:** Right? Like your job is education, making certain that the the information is understandable, they understand the risks, benefits, and alternatives of each of these decisions, what your recommendations are, and make sure that they understand and are making an educated decision about that. Like that's how it works, but they have patients have to ask the questions. They have to let us know when they're not clear on things.

**[6:42] Speaker A:** Exactly.

**[6:42] Speaker B:** know? And so I think that that's really important.

**[6:44] Speaker A:** There's some gynecologic conditions and I want to share this so that our listeners here understand and I don't want to scare them, but this is important because again, we can intervene sooner and open up that runway for them. Um endometriosis carries a 23% higher cardiovascular disease risk. Um probably driven by chronic systemic inflammation, a history of uterine fibroids, which affect up to two-thirds, me included, of women with reproductive age has a 32% increase MI risk, so heart attack risk. And then I have patients with both diagnoses, you know, who have never had a single cardiovascular conversation with any physician. And it's not in my wheelhouse, right? I'm a I'm a gynecologist. I can start the conversation. Who should she see? What would be her next step?

**[7:38] Speaker B:** Well, I think you have to have an engaged cardiologist to have that. Otherwise, they're not even know why the patient's there. You've sent a 35 32-year-old woman into the office with fibroids who's got two young kids running around the exam room and all they're like, why are you why are you here? So I think this goes back to that communication piece. I think that this is where that team management would make so much sense because again, this theme of we have this runway, opportunity to change those numbers.

**[8:10] Speaker A:** Mhm.

**[8:10] Speaker B:** We know what's going to happen if they do nothing. This, you know.

**[8:15] Speaker A:** And so, you know, until we change that mindset, I think it's going to be very difficult to get have a better understanding of which levers are most important. I honestly, I don't know. I don't know why exactly those connections Yes, systemic inflammation, but in this younger age population group with this problem, where are we going to really make the biggest difference with that? I I just I don't know that we even have that answer cuz no one's really doing it yet.

**[8:47] Speaker B:** Right. I There's They're starting. Again, it's all observational at this point. Um but it would be beautiful to see taking these women with endometriosis fibroids and then breaking down all these risk factors and where is the biggest intervention going to be for them? Is it cholesterol? Is it lifestyle? Is it nutrition? You know? Is it treating her endometriosis?

**[9:08] Speaker A:** You know, what keeps ringing with me is what you what you opened with was like there's so much apparent low-hanging fruit here where we know there's such a problem, you know, with with really reasonable steps. I think this is a perfect example of that.

**[9:25] Speaker B:** On this guideline and we I will put a link to the guidelines for our listeners if they want to look through them. They're very extensive. But like formal reproductive risk markers now include early menopause we mentioned earlier, premature menopause which is even greater before age 40, polycystic ovarian syndrome now called PMOS, and then early periods before the age of 10. You know, there's something about that lifetime exposure. And then adverse pregnancy outcomes including preeclampsia, gestational diabetes, gestational hypertension, preterm delivery, and um recurrent spontaneous pregnancy loss.

**[10:01] Speaker A:** Think of the number of women that that includes.

**[10:03] Speaker B:** It's huge.

**[10:04] Speaker A:** I mean

**[10:05] Speaker B:** It huge. So why is cardiovascular disease is number one killer of women.

**[10:10] Speaker A:** Yeah.

**[10:11] Speaker B:** Right here.

**[10:12] Speaker A:** Yeah. Certainly, certainly has to be a component.

**[10:15] Speaker B:** Let's talk about tests. That's what everybody wants to know. What tests do I need? Um so we've talked about a basic lipid panel and then adding in these two extras. Let's go over that again.

**[10:26] Speaker A:** Apolipoprotein B is a more granular way of looking at your cholesterol panel, LDL. More specific, looking at dangerous particles. LP little A is looking at that genetic component. For women, it should be tested early. Yes or no, it is a level of and it does fluctuate. It does fluctuate. And postmenopausal transition because of the reasons, the clearance reasons that that we discussed. The other things that I think are really important are to know your glucose metabolism, which includes three things. Just a straight fasting glucose to know where you stand, a hemoglobin A1C, which is just a long-term It's the more longer film version of of how you do with your blood sugars. And then a fasting insulin level is so important because blood sugars may stay relatively normal and your pancreas is trying to keep up. Again, this is about that insulin resistance again. The insulin is cranked up.

**[11:29] Speaker A:** It's all the way up here. Well, it's keeping that blood glucose relatively normal, but at some point the pancreas is going to be done. It can't keep up anymore. And the cells are going to stop responding. And so those those really I think are the really important blood biomarkers, if you will, that are really specific to cardiovascular medicine.

**[11:53] Speaker B:** What about the testing for disease in the arteries? So what is a calcium cardiac score? It's so popular. I I'm recommending it to certain patients.

**[12:05] Speaker A:** Yes.

**[12:05] Speaker B:** But please explain what that is and then how that differs from an angiogram. And who should have these tests?

**[12:12] Speaker A:** Yes.

**[12:12] Speaker B:** A calcium score CT scan measures exactly that. The amount of calcium in the coronary arteries. In the Okay. So, as plaque forms in the artery, it starts off as soft plaque. Over time, that plaque then hardens and calcifies that can then be seen on this calcium scoring test. Here's the issue. Calcium scoring CT scan does not identify soft plaque at all. Now, is there value to know that you have hard plaque? Well, I think in certain patient populations there is value there as a baseline screening test when we're trying to decide you know, when you define baseline screening test, it's to take a patient without symptoms and predict their risk of getting a disease. And I think that calcium scoring is fairly limited in that scenario. Are there certain scenarios when it can be helpful? Sure, if there's patients that are trying to decide between a statin and they have to see that they actually have something in the arteries and yes, but here's the thing.

**[13:38] Speaker B:** If we know that the apo B and the LP little A are abnormal, the calcium CT scan isn't going to change what we need to do.

**[13:48] Speaker A:** Okay.

**[13:49] Speaker B:** We know that we still need to do the apo B. We need to treat the particle count accordingly first. So, are there certain clinical scenarios and have I used it? Yes. Does a zero calcium score mean you don't have a risk of for a heart attack? No. It doesn't. And that's the question that you're that you're asking.

**[14:12] Speaker A:** in our world, it's being used as a reason to deny hormone therapy. You know, if your score is above a certain level,

**[14:21] Speaker B:** Explain.

**[14:21] Speaker A:** I cannot understand why.

**[14:23] Speaker B:** I don't understand that.

**[14:24] Speaker A:** Yes. What about an angiogram?

**[14:27] Speaker B:** Okay. So, before we get to angiogram, which is the gold standard for determining whether you have blockage. Now, that's where we put dye, cardiologists put dye in the actual arteries and can create a road map and see if there blockages. That's done through the wrist or the groin through the artery through a little catheter. But there's there's risk involved. It's a an invasive It's an invasive procedure. The risks are low, but it's not risk-free. So, what are the intermediate steps? Well, we have to kind of split patients into two groups, patients with symptoms and patients without symptoms. Now, if somebody comes in with crushing chest pain and they have signs and symptoms of a heart attack, they're going to go directly to angiogram because as we mentioned, time equals heart muscle saved. We want to do an angiogram, potentially put a stent in and relieve that obstruction.

**[15:22] Speaker B:** So so that's one category. They go direct to angiogram. Then you have the individuals that come in with what I call kind of stuttering type symptoms. You know, they exercise a little bit, they have to sit down. They used to be able to walk 2 miles. Now, they can only make it a half a mile around and they have to sit down and that's getting progressively worse and you're not sure what it is. There are non or less invasive ways of evaluating whether this is valvular disease or potentially coronary disease. The fastest way is to do an echocardiogram, which looks at the valves itself and it also looks at heart function. Strong heart, an indicator for living longer. Weak heart, sign for, you know, increased mortality. Makes good sense. People with strong hearts do better than people with weak hearts. And it also looks directly at that valvular structure.

**[16:20] Speaker B:** A stress echocardiogram, I think is the best non-invasive stress test. Even

**[16:28] Speaker A:** What is that?

**[16:30] Speaker B:** So with a echo probe, either they have you walk on the treadmill at a certain um very prescribed amounts of effort and then look at the heart function, looking at the wall motion of the heart to see if the heart is functioning in a segmental and very um coordinated fashion. Or if you're unable to walk on the treadmill, they can put you on an exercise bike or they can be pharmacologically raise your heart rate and look at at the echo. I think that the stress echo is the most functional way to actually see if one section of the heart, in other words, if you were to have blockages in one artery, isn't moving properly. If that's positive, then that would then trigger an angiogram to look for a problem further and potentially fix it. Um but short of short of those tests, you know, there really aren't any non-invasive tests that are going to tell you

**[17:31] Speaker A:** a soft plaque?

**[17:32] Speaker B:** Right. Now, some of the newer CT scans do put dye in the arteries and give somewhat of a picture. The CT angiograms give you somewhat of a picture, but it's not the same as an angiogram and it's not as definitive and the data is not as reliable.

**[17:53] Speaker A:** And there's no place for this in an asymptomatic patient.

**[17:56] Speaker B:** I would never say

**[17:57] Speaker A:** woman with risk factors

**[17:59] Speaker B:** different I I wouldn't I wouldn't say no place for it. I think it would be individualized and and looking at the decision-making tree. I think that I would look towards the standard areas first, like what's her blood pressure, what her labs look like, you know, how you doing symptomatically, you know, are you your fatigue level changed? Are you able is your exercise tolerance going up or down? Like, good, solid history, physical, basic lab before you look towards laying your hat on something that may unfortunately create a false sense of security.

**[18:43] Speaker A:** This podcast is sponsored by Midi Health. Have you noticed the conversation around menopause is suddenly everywhere? It's trending on social media, celebrities are opening up about their symptoms, and conversations that used to happen in whispers are finally out in the open. And honestly, it's about time. For decades, women were dismissed, ignored, or told their symptoms were just part of aging. And while I'm glad the conversation is happening, here's the truth. Menopause care isn't a trend. It's long overdue medical care that women have always deserved. If you've been listening to me, you know this isn't new territory for me. This is my life's work, helping women navigate perimenopause and menopause with real science. That's why I want to tell you about Midi Health. Midi is a virtual menopause clinic staffed by clinicians who listen, who take your symptoms seriously, and never utter the words, it's all in your head.

**[19:41] Speaker A:** Like me, Midi focuses on your health span, not just your life span. That means taking a comprehensive look at your metabolic health, bone density, cardiovascular risk, and cognitive function because all of it matters. Midi delivers the kind of proactive, evidence-based care I've always believed women deserve. And the best part, women in all 50 states can access personalized care, and it's almost always covered by insurance. So yes, I'm glad menopause is finally getting attention, but don't settle for noise. Get care from clinicians who are in this with you for the long haul. Book your virtual visit today at joinmidi.com. That's joinmidi.com. Insurance coverage varies. Check with your plan for coverage. Let's move on to treatments, medications. Statins are all over the internet and I've seen them portrayed as miracles, as the devil. What is a statin and what do we use it for?

**[20:44] Speaker B:** Well, first we established earlier that cholesterol is necessary in the body. I don't argue with any of that at all. If we didn't have cholesterol, we would not be alive. Brains, entire body. Statins, in my opinion, and I think in the data it would be supported, have saved and helped more people than they have harmed. They have saved more lives and moved the needle in cardiovascular disease more than any single one intervention in the last 25 to 50 years. Okay. Why? Because we know that apo B is causal for coronary disease and statin therapy is very potent as far as lowering apo B levels. And we have the outcome data to prove it. It's not just we're lowering apo B levels and we don't know if people have less heart attacks. The outcomes are there. Now, that said, statins aren't the only option.

**[21:51] Speaker A:** Okay.

**[21:52] Speaker B:** You know, they are not the only option. What are statins? Well, let's go back to the liver as the command center because this is where all the medications make sense. Okay? The liver makes cholesterol. The liver takes cholesterol from the bloodstream. Statins affect both. Decreases production and it increases those LDL R receptors on the liver that pull the apo B. Bempedoic acid, which is a non-statin medication, works very similar to a statin, but doesn't have the side effect profile that that say statins can have for people.

**[22:30] Speaker A:** Okay.

**[22:31] Speaker B:** Ezetimibe.

**[22:32] Speaker A:** Mhm.

**[22:33] Speaker B:** Really cool mechanism with the way ezetimibe works. So it works in the GI tract.

**[22:39] Speaker A:** These are new and very exciting.

**[22:41] Speaker B:** Well, they're not relatively new. It's just they don't get talked about as as adjunctive or other options cuz, you know, the PCSK9 inhibitors, Repatha being one, and now there's an oral agent. Basically, these PCSK9 inhibitors, they inhibit the protein that breaks down those receptors.

**[23:02] Speaker A:** Mhm.

**[23:02] Speaker B:** Our bodies naturally do that. And there's people that are born with that, like they win the genetic lottery.

**[23:07] Speaker A:** Mhm.

**[23:08] Speaker B:** And their cholesterol levels, their ApoB levels are near zero, and they have a near zero incidence of heart disease. It's like the Mendelian randomization for this argument right here. Well, what the PCSK9 inhibitors do is it prevents the destruction, so it upregulates all of those receptors, and it's very very powerful. I'm on it

**[23:27] Speaker A:** Mhm.

**[23:27] Speaker B:** after after my stent. Pulling those ApoB particles out of the bloodstream, and it works very quickly. Very low side effect profile. Now there's an oral agent, so you don't have to inject yourself, so it's even even better tolerated. Now do statins have side effect profiles? Yes. They are real. I had it with statins when I started. I had proximal or thigh weakness, you know, that we had to dose adjust, ended up on Repatha. I mean, I I'll tell you that they are real. Does it mean that it should absolutely nullify the decision to treat cholesterol? Absolutely not. There are other options, and there's even modifications within the statin world, you know? And those things need to be included in this conversation. It's not it's not so black and white. There's there's there's a it's a dial with this and we're dealing with this really kind of beautiful control mechanism when it comes to how medications work and what individuals will tolerate.

**[24:38] Speaker A:** Let's kind of break it down for a woman listening. She's 52, fully menopausal, wants a full cardiovascular screening. So like walk through what you would recommend for her.

**[24:48] Speaker B:** 52, no symptoms, just she's asymptomatic, no family

**[24:53] Speaker A:** history. Mom in her 70s, you know, had a heart attack.

**[24:58] Speaker B:** Did have a heart attack, family history. Yeah, I think that obviously full history, physical examination to see make sure blood pressure, blood pressure most easily modifiable risk factor that we have in and it affects half of of the people in the US and most people don't even know. That's why they call it the silent killer. So so important, basic basic physical findings and then the labs that we just discussed. I think that apo B, LP little A, fasting insulin, serum glucose, and hemoglobin A1C. And then with her family history, I think that at least an echocardiogram, if not a stress echo, certainly would be worthwhile at that age depending on how fit she was, how I mean some people are are exercising at a certain level that it's unnecessary to do that and so I would temper that, but I think that in this conversation, particularly when people are going to go in and have this conversation with physicians, I would always air

**[26:00] Speaker B:** on the side of at least ask that question, is it appropriate for me

**[26:04] Speaker A:** Okay.

**[26:04] Speaker B:** as opposed to you don't need this.

**[26:06] Speaker A:** We know estrogen is protective and I try to tell my patients I can't give you back your 25-year-old ovaries. You know, the estrogen that your ovaries made is not exactly the same as what I'm giving you. It's going to go through a different pathway and your body's going to react in different ways and oral's different than transdermal. But let me be clear, no guideline recommends estrogen for prevention yet.

**[26:28] Speaker B:** Yeah. I I I and I think that's reasonable with where we are right now, but I think that it is very clear that it is a valuable lever to utilize as an adjunct to lifestyle because it it changes the ability of women to actually do the things they need to do. And so I don't know that it ever needs to be a guideline because it's going to become so implicit.

**[26:59] Speaker A:** Mhm.

**[27:00] Speaker B:** And and I think that's I think it's smart right now to to not have it as a guideline, honestly, because we don't have that outcomes data we do with these other blood pressure all the stuff. And so I think given the gravity of what can happen, we would be full-hearted to make a you know a pivot of that nature at this juncture. And I just think that there's some things in medicine that don't require a a randomized control trial, you know. I remember an old attending of mine every time we'd start down their studies like you know there's no randomized control trial that tying off blood vessels in surgery reduces blood loss, but you do it anyway.

**[27:45] Speaker A:** That's funny.

**[27:46] Speaker B:** And and you go

**[27:47] Speaker A:** might have to steal that.

**[27:48] Speaker B:** you go yes, exactly. And so they're just there's certain things in medicine that make good sense.

**[27:56] Speaker A:** I tell patients when we're looking at longevity, okay, when we're looking at decreasing the risk of frailty, decreasing the risk of dementia, decreasing the risk of heart disease just giving you menopause hormone therapy without the concomitant lifestyle that you need to have is likely not going to do much.

**[28:14] Speaker B:** I love that.

**[28:14] Speaker A:** You know in the long term. Short term, yes, your hot flashes will get better, your bones will be a little bit stronger, but a lot stronger actually, but your you know without the nutrition piece, the stress reduction piece, the community piece, you know the relationship piece, all the things that when we look at when you talk to the people who actually take care of old people, you know, and not this theoretical like saunas and plunges and all this, you know, the fancy stuff, I'm like, it's pretty basic. And if you're not doing these things,

**[28:48] Speaker B:** Yes.

**[28:49] Speaker A:** hormone therapy is likely not going to move many levers in 20 years.

**[28:53] Speaker B:** I I could not agree more. And I think there's kind of two ends of the spectrum

**[28:58] Speaker A:** Mhm.

**[28:59] Speaker B:** with when we're talking about medications in general, you know, we we kind of had this current culture, this maximize, maximize, maximize, maximize culture where if God forbid you need a cholesterol medication or a blood pressure medication, you have failed.

**[29:15] Speaker A:** Yeah.

**[29:16] Speaker B:** You did not pull all the lifestyle levers.

**[29:19] Speaker A:** your way.

**[29:20] Speaker B:** Right. It's like, no. You just that's the next lever. Like, that's awesome. You've done the work that everything else stands on. You know, and then you've got the other side of the spectrum, you know, where in other words, medications are a failure. And then you've got the other side where medications become a crutch. It's the reason that, well, I'm I'm on my hormone replacement. I feel pretty good. I don't need to I don't need to exercise. And part of that, honestly, I think is physician responsibility too because there's that same spectrum of the physicians that give out medication like a Pez dispenser, you know, for everyone old enough to know what the Pez dispenser is. Um versus I think actually a more dangerous mindset for physicians that are the, oh, you're doing great. Let's just see how you do because they know that the that the patient doesn't want the medication.

**[30:19] Speaker B:** They're like, well, we'll just check it next time. These are all risk-benefit decisions. And it's about mitigating that risk for your patient. They count on us to do that. And neither ends of those spectrums are good either for physician or for patients. It's somewhere there in the middle like you say, like, do the work, and then do the things that help you do the work better.

**[30:42] Speaker A:** So, GLP-1s. It's really revolutionizing my practice.

**[30:48] Speaker B:** Yes.

**[30:48] Speaker A:** How what

**[30:50] Speaker B:** Man, I've got I've got all kinds of all kinds of confessions to make on on the podcast today. I have come 180 on GLP-1s. I have to be very upfront.

**[31:01] Speaker A:** Okay. What does that mean?

**[31:03] Speaker B:** I was very critical when they first came out. I was just like

**[31:06] Speaker A:** cuz I was preaching lifestyle, you know, like

**[31:09] Speaker B:** we go. The drive-through weight loss, another quick way. Oh, I can't wait to see all the problems that patients have had. I could not have been more wrong.

**[31:21] Speaker A:** Mhm.

**[31:22] Speaker B:** And in several in several facets, number one, there are patients that have struggled their entire lives that I have watched absolutely transform their existence. Number two, there are individuals that have struggled with just getting that motivation to start, like they really want to, but they don't feel comfortable going into the gym or they don't feel comfortable, whatever it may be, that this has added a runway that has really worked.

**[31:53] Speaker A:** Mhm.

**[31:54] Speaker B:** And then you start to look at the added components, the added benefits from cardiovascular to malignancies to all of these things, I think you would be foolhardy not to take a step back and say, hm, I think there's some value here. I mean, I got asked what I thought the most significant drug development has been in the last five years, and I said GLP-1s.

**[32:21] Speaker A:** Oh, for sure.

**[32:21] Speaker B:** Because if we can cure the obesity problem,

**[32:25] Speaker A:** Mhm.

**[32:26] Speaker B:** I think that we will really move the needle from a cardiovascular standpoint, from a from a frailty standpoint. And there's in the European countries now that are looking at this from a public health standpoint, making it over the counter.

**[32:40] Speaker A:** Wow.

**[32:41] Speaker B:** Right.

**[32:52] Speaker A:** you know, all the same levers, but

**[32:55] Speaker B:** I don't. Yes.

**[32:56] Speaker A:** effects. Every drug has risks and benefits. This could absolutely change your life, but there's a way to do it and that you end up healthier in the long run and you're not and you never want to sacrifice muscle and bone, which weigh a lot to get to a number on the scale.

**[33:12] Speaker B:** That 's right. That's right. But I I I I freely admit I was absolutely wrong from from impression one and and I'm really excited about what's to come.

**[33:22] Speaker A:** So my favorite of your viral videos are lifestyle. And that's how I discovered you. You sitting in a plaid shirt somewhere talking about what you ate or something. It was really good. So research shows and I was fascinated to read this that women benefit more from physical activity in terms of cardiovascular outcomes than men do.

**[33:44] Speaker B:** Mhm.

**[33:44] Speaker A:** like more worth it for a woman to work out, you know, for her heart.

**[33:48] Speaker B:** Yeah.

**[33:49] Speaker A:** What type of movement is most protective? Let's kind of get into the details here. At what intensity? I mean, everybody wants to know, tell me what to do.

**[33:56] Speaker B:** Sure. Well, I think a a big portion of that of that benefit data is kind of the flip side to the impact of those risk factors as well are greater for women. And I think a lot of the data too comes from individuals that are sedentary, doing nothing, going to

**[34:17] Speaker A:** Like any movement's better than none.

**[34:19] Speaker B:** Zero to one, the benefit is is exponential going from zero to one than it is nine to 10. Not that nine to 10 isn't good. Like go for your A plus. I'm all for that. But the the the gain that you get is amazing even if you've never done anything. And I think the key before we get into the specifics is it's never too late. Like, you know, people really convince themselves that I've never exercised. I've waited this long. The damage is done. That's just not the case. I mean, Ben Levine showed in his in his cardiac study of of middle-aged primarily men doing, you know, high-intensity workouts over two years that their echocardiograms actually improved. Their hearts got younger. And their VO2 max, their their cardio respiratory capacity went up.

**[35:17] Speaker A:** Mhm.

**[35:17] Speaker B:** And these are people that had never exercised.

**[35:19] Speaker A:** So I I try to meet patients where they are. So the conversation I have with a sedentary individual is very different than someone who walks every day. Is very different than someone who who does Pilates or goes to the gym or has yoga.

**[35:30] Speaker B:** Sure.

**[35:30] Speaker A:** And so but what is the data really say?

**[35:33] Speaker B:** Yeah. I mean, I think that that's obviously the most effective way to to counsel patients. Otherwise, they're just not going to listen to you and it's not they're not going to stick with their program. I think that globally it's you want aerobic training and strength training. The question is what does that look like for each of these individuals? Well, I think walking is wonderful.

**[36:01] Speaker A:** Mhm.

**[36:01] Speaker B:** I think it is foundational to to health to our health journey. I use walking a lot. Is walking going to fix your bones? Is walking going to maintain bone strength? Walking is not going to make your bones strong.

**[36:17] Speaker A:** Mhm.

**[36:18] Speaker B:** It's not. You got to lift heavy stuff. And that's heavy for you. That can be body weight movement. It's fine. And scale that over time. What should the mixture be? You know, everybody's got these magic numbers of 150 minutes of exercise. I mean, you've heard them as many times as I've heard them. I really think it's about it's about defining an activity that you enjoy doing that you can, then you can move your body across a distance of some sort, even if it's on a treadmill, across a distance and and move heavy stuff either off the ground or across the distance uh you know of a room or whatever works for you. Because to pick some number that I'm going to put on it that someone can't stick with means it means it means nothing. Consistency is is more important than what you're actually doing.

**[37:18] Speaker B:** So I really feel like just check those boxes that your body is moving that if once or twice a week you can get yourself to a breathless place where you can't have a conversation, great. If you can't do that initially, work up to that.

**[37:34] Speaker A:** Okay.

**[37:35] Speaker B:** And then two to three times a week there's got to be some resistance placed on the muscles. Muscles only get bigger if they're placed under tension.

**[37:44] Speaker A:** Gabrielle talked about it's a stimulus. It's not so much progressive overload anymore, it's progressive stimulus. So that stimulus could be a heavier weight, could be doing it faster, could be adding a jump, could be but like changing the stimulus to something that's more challenging will have just as good of outcomes as picking up that heavier weight. So we limit the entry.

**[38:05] Speaker B:** for sure and I and I think that that also widens the spectrum of people's choices. And obviously we're we've spoken to the sedentary folks. I don't want to forget the hardcore individuals out there. I might be sitting across from one right now. They need to remember that rest and recovery is where muscle growth and and our bodies actually can can can get stronger.

**[38:31] Speaker A:** get stronger in the gym, they get stronger in bed.

**[38:32] Speaker B:** That's right. Your biceps don't grow while you're doing while you're doing curls. You're actually tearing those muscle fibers at that point. It's during the recovery phase where you are giving your body adequate protein for building blocks, hydrating and allowing those body those muscle groups to rest, that's where the magic is.

**[38:50] Speaker A:** Now, how do you counsel your patients about nutrition?

**[38:52] Speaker B:** Again, I'm just I'm very careful because it's just such a it's such a sensitive topic, but I really like to offer guidelines and I think that I think that nutritional plans start in the grocery store.

**[39:07] Speaker A:** Mhm.

**[39:08] Speaker B:** And success starts when you walk in the door. I think number one, make a list. Don't go hungry.

**[39:14] Speaker A:** Yeah.

**[39:15] Speaker B:** Helps a lot. I mean, these are simple things, but like they really they really matter. Um you know, shop shop on the exterior. Try to stay out of the aisles the best you can. That's that's where the the whole foods live. Lean lean meats if that's something that works for you. If you are look, processed foods are not necessarily bad for you, you know, but you have to pick and choose. Remember that the front of the can't an advertisement, the back of the can has the ingredients. We're all drawn in by the front of the can. I try to use about an 80/20 rule. If I can hit my goals 80% of the time and 20% of the time I fall off, I consider that I consider that a win. Limit added sugar and processed sweets. And, you know, our bodies need saturated fats, but only to a certain level.

**[40:07] Speaker B:** Because what happens is if we eat too much saturated fats, are those receptors on the liver actually down regulate because the liver says, oh, we have enough.

**[40:17] Speaker A:** Oh, wow.

**[40:18] Speaker B:** Yes. And so what can happen is when people substitute for sugar and those processed sweets, they're like, oh, I'll eat more meat. Fine, just make sure it's lean meats and then you're not adding a an extra dose of saturated fats to your diet because that same mechanism works in the liver where it says, oh, we've got enough. We'll just pull the receptors back and then you've got more circulating.

**[40:46] Speaker A:** Do you ever recommend any supplements?

**[40:48] Speaker B:** Yes.

**[40:49] Speaker A:** Um, I think that creatine is something that the vast majority of individuals should consider taking. It's one of the most well well-studied supplements on the market. The the impacts are far-reaching from muscle maintenance to growth to the neurocognitive business benefit to recovery, all these things. You know, um, there's a lot of myths out there about it that, you know, hair loss, they can make make women bulky, it's a bodybuilder drug, it's a steroid. It is not a steroid. So creatine is definitely on on the list. Um, you know, others I think should be directed to the individual. I think that to make blanket supplements is is really not it's not fair. But creatine is one that I think is fairly ubiquitous for everyone.

**[41:44] Speaker B:** specifically any thoughts on coenzyme Q10 um, or antioxidants?

**[41:49] Speaker A:** The data on those is basically in heart failure patients

**[41:53] Speaker B:** Okay.

**[41:53] Speaker A:** where they've they've showed some improvement in patients that already have a weaker heart. And so I think that mechanistically CoQ10 is beautiful.

**[42:03] Speaker B:** Mhm.

**[42:03] Speaker A:** But we don't see the outcome data to say that this is something that's going to really move the needle to make your heart stronger. I think that, you know, and I think this way about several supplements that that I take that no, there's no a outcome data, but I know these particular levels drop as I age. So why wouldn't I stack the deck in my favor? Just like creatine. Exactly. I know that I'm already in a muscle loss phase.

**[42:27] Speaker B:** Mhm.

**[42:28] Speaker A:** I need to do everything I can to stack the deck in my favor.

**[42:32] Speaker B:** What do you take? The audience is going to want to know since you mentioned it.

**[42:36] Speaker A:** creatine and I do take either NAD or an NMN precursor, glutathione

**[42:44] Speaker B:** Okay.

**[42:45] Speaker A:** is also part of the routine, and magnesium at night

**[42:49] Speaker B:** Mhm.

**[42:50] Speaker A:** is I I struggle with sleep. It is my Achilles heel and

**[42:54] Speaker B:** next question.

**[42:55] Speaker A:** and uh it is it it magnesium makes a dramatic difference for me.

**[43:00] Speaker B:** I'm happy for you.

**[43:01] Speaker A:** Yes.

**[43:02] Speaker B:** Um so perimenopausal women have some of the worst sleep of any population and it doesn't get better in post menopause. Um we there's many things hitting our sleep, right? For women specifically, you know, if you're having hot flashes at night, it's going to wake you up. Um but also this cortisol dysregulation, um anxiety, fragmented sleep, um what does that do to her cardiovascular risk? It's now recognized as a risk factor, right?

**[43:28] Speaker A:** Absolutely.

**[43:29] Speaker B:** Individual Because the girls aren't sleeping.

**[43:32] Speaker A:** Yeah.

**[43:32] Speaker B:** You know.

**[43:33] Speaker A:** And if your sleep's off, everything is off.

**[43:35] Speaker B:** is off.

**[43:36] Speaker A:** And that really kind of

**[43:37] Speaker B:** hunger, your weight, your stress, your depression, your I mean it's crazy. Your risk of dementia. So

**[43:43] Speaker A:** If your sleep is off, everything is off and it's like just another component of this perfect storm of perimenopause and menopause that is like yes, it's another lever, but sleep is is like is different than all the other levers, right? Like I can control what I put in my mouth

**[44:04] Speaker B:** most of the time.

**[44:05] Speaker A:** You could control your exercise most of the time.

**[44:06] Speaker B:** up at the gym, but the more I try to control my sleep, the worse it gets.

**[44:12] Speaker A:** Yeah.

**[44:12] Speaker B:** You know, I had a friend of mine say to me recently we were having this conversation. She goes, you know, I was putting my kids down and they said, I'm trying to go to sleep. And she looked at them she goes, you're not supposed to try to go to sleep. You're just supposed to go to sleep. And I've had to change my relationship with sleep because I think that after, you know, after 25 26 years of being on call, I'm on Defcon 1 all the time. Like this little the smallest change in the room and I and I'm not anymore, thank goodness, but the the little the smallest distraction I'm I'm wide awake even still. I'm still working on it. And yes, it is a documented cardiovascular risk factor. No question. particularly with sleep apnea because of the apneic spells and then

**[44:59] Speaker A:** are not being picked up as much as they should. So I'm like, listen, if if we've got your hot flashes controlled and you're still getting up at 3:00, you need a sleep study.

**[45:06] Speaker B:** I heard a statistic the other day, and I don't I I didn't see this myself,

**[45:10] Speaker A:** Uh-huh.

**[45:11] Speaker B:** but that 83 million individuals suffer from sleep apnea and like only 10 to 20% are actually treated or diagnosed. I mean, that's a staggering number. But I think that that's something that

**[45:27] Speaker A:** Right. It's definitely related to obesity, less so in women. And if you're not snoring, it doesn't mean you don't have it. So if we've done everything in my world, the magnesium, the hormone therapy, the progesterone, and you're still waking up, you deserve a sleep study.

**[45:42] Speaker B:** Yes. For sure sure. At least you know.

**[45:45] Speaker A:** Mhm.

**[45:46] Speaker B:** least you know if you're having those drops. And so for me, I've really had to like totally change my relationship with sleep. And I think that's why sauna has has been so important because a nighttime sauna session

**[45:58] Speaker A:** Let's talk about it.

**[45:59] Speaker B:** raises your core temperature. One of the triggers to go to sleep is a fall in your temperature in the evening.

**[46:05] Speaker A:** Mhm.

**[46:06] Speaker B:** So by raising my temperature, and I don't do an intense sauna session, like I do 11 12 minutes at a moderate temperature because obviously an intense session can really rev you up. Just enough to get my core temperature up. I I just let my body temperature come down naturally over 15 20 minutes, and then I'll shower and I go to sleep

**[46:29] Speaker A:** Okay.

**[46:29] Speaker B:** with magnesium and I ate sleep. But it's all these it's all these pieces. Dark room, you know, makes a huge difference. Flip my flip my phone over, you know, I can't turn my phone off. My parents are older. I've got kids spread out at various places. I don't feel right about turning my phone off at this juncture in my life, but at least it you don't get those notification lights and

**[46:52] Speaker A:** pings from

**[46:53] Speaker B:** no pings, none of the none of the things. And I'll tell you, look, it's better. I'm not there yet.

**[47:00] Speaker A:** I mean and you can only allow the notifications to come through from your parents and your kids, you know. So like for our listeners, you know, you you I'm the same way. You know, my mom's at end of her life and I'm we're waiting and you know, I don't want to miss that call. And so my kids also are living out of state, you know. And so yeah.

**[47:20] Speaker A:** Um okay, so let's wrap this up. Um let's give an action plan to our listeners. So if someone's listening in their 30s or more than likely and with my listeners, someone's going to send this to their 30-year-old daughter. Um before the you know, before menopause enters the chat, before her LDL jumps, before her blood pressure goes up, like what can she be doing young? How do you talk to your kids about this?

**[47:42] Speaker B:** It's hard to have these conversations where people feel good.

**[47:45] Speaker A:** Yeah.

**[47:45] Speaker B:** You know, it really it really is. But I'd say there's three things. Number one, know your numbers.

**[47:53] Speaker A:** Okay.

**[47:54] Speaker B:** The earlier the better. What do I mean? ApoB, Lp(a), the other numbers we talked about, and your blood pressure. Get a home blood pressure cuff. I know, you know, maybe what you played with when you went to go visit your grandparents, but believe it or not, it's the best way to take your blood pressure at home. So know your numbers, know them early because the earlier you intervene, particularly if we go back to that model, if we if we can lower the amount of things that are attacking the artery at an earlier stage of your life, the better chance we have to take that runway out even further. That'd be number one.

**[48:31] Speaker A:** Okay.

**[48:32] Speaker B:** Number two, move your body every day. Aerobic and some sort of strength resistance training, whatever works for you. I don't care. I want it to be fun. Find the hobby.

**[48:45] Speaker A:** You can I'd say can we check more than one box when we do this? Like what's going to lower your stress level? Which one is going to bring you joy? You know, is going for a walk with your girlfriends and you come back rejuvenated, rejoiced, you've connected with the community, with nature. Like we're checking three boxes for your longevity right there.

**[49:03] Speaker B:** Sure. I would say, well, tell me what your hobbies are.

**[49:05] Speaker A:** Mhm.

**[49:06] Speaker B:** Cuz sometimes your hobbies are actually pretty healthy for you, you know? Let's talk about it. And the third is be just be thoughtful about what you put in your mouth. And I think if you kind of follow those three basic guidelines, you'll be pretty well set moving into later stages of your life.

**[49:26] Speaker A:** Excellent. If a woman doesn't have a cardiologist yet and her primary care doctor hasn't started this conversation with her, but she's listening, she knows her numbers, she knows oh gosh, I'm in increased risk. How can she start that conversation?

**[49:39] Speaker B:** Directly is how to have that conversation, right? I mean, we touched on the fact that this is a relationship. And a relationship requires communication and communication requires two people, you know, you mentioned agency of the patients earlier, agencies of these women to you you have to speak up.

**[50:00] Speaker A:** Mhm.

**[50:00] Speaker B:** You know, that's the only way you're going to to get what you need and and what you want. There's nothing wrong with that.

**[50:06] Speaker A:** And what's the one thing you wish every woman knew about her heart and her hormones and and you know, what people really aren't talking about quite yet?

**[50:14] Speaker B:** You know, I I look at this as being this kind of collision of of predetermined worlds between atherosclerosis and the transition uh in into menopause. It's like this intersection.

**[50:34] Speaker A:** Mhm.

**[50:35] Speaker B:** We have to control what we can actually take control over. You know, as physicians, we do a great job of treating heart attacks, getting the blood pressure down, treating the hormones. But once you are discharged from the hospital or you leave the clinic, it's your turn. It's your turn to take responsibility and doctors can save you, but we can't heal you. Doctors can save you, but we can't heal you. Only you can heal yourself.

**[51:15] Speaker A:** That's awesome. How can our listeners find you?

**[51:20] Speaker B:** Dr. jeremylondon.com, all the social platforms. We have a newsletter, a free newsletter that goes out several times a week, and podcast and all the usual spots.

**[51:30] Speaker A:** Well, thank you for coming on Unpaused. You've been a great guest, and hopefully our listeners have learned quite a bit.

**[51:35] Speaker B:** This was awesome. I had so much fun.

**[51:39] Speaker A:** You can find full episodes of Unpaused on YouTube at Dr. Mary Claire. Also, you can find me on Instagram at Dr. Mary Claire and get honest and accurate information on health, fitness, and navigating midlife at thepauselife.com. Unpaused is presented by Odyssey in conjunction with Good Roommate Media and Longwave Digital. This episode was sponsored by Midi Health, the first virtual clinic created for women, by women for the treatment of menopause. Don't let anyone tell you menopause is something you have to suffer through alone. Midi can help. Visit joinmidi.com to learn more.
